NantHealth (NH) Stock Price, News & Analysis

Company Overview

NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.

Key Stats

• Today's Range: $0.0120 to $0.0120
• 50-Day Range: $0.0030 to $0.0130
• 52-Week Range: $1.24 to $9.75
• Volume: 3 shs
• Average Volume: 38,073 shs
• Market Capitalization: $92.44 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NH Stock Analysis - Frequently Asked Questions

How have NH shares performed this year?

NantHealth's stock was trading at $0.0031 at the start of the year. Since then, NH shares have increased by 287.1% and is now trading at $0.0120.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) posted its quarterly earnings data on Thursday, November, 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by $0.02. The business had revenue of $14.36 million for the quarter, compared to the consensus estimate of $17.70 million.

When did NantHealth IPO?

NantHealth (NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NantHealth investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Gilead Sciences (GILD).

Company Calendar

• Last Earnings: 11/04/2021
• Today: 8/09/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Data processing & preparation
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:NH
• Previous Symbol: NYSE:NH
• CIK: 1566469
• Web: www.nanthealth.com
• Phone: (855) 949-6268
• Fax: N/A
• Employees: 340
• Year Founded: 2007

Profitability

• EPS (Trailing Twelve Months): ($7.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$67.78 million
• Net Margins: -94.67%
• Pretax Margin: -95.06%
• Return on Equity: N/A
• Return on Assets: -39.82%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.64
• Quick Ratio: 0.64

Sales & Book Value

• Annual Sales: $67.68 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($30.72) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 7,703,000
• Free Float: 2,981,000
• Market Cap: $92.44 thousand
• Optionable: Not Optionable
• Beta: 1.82